WebProNews

Tag: vaccine

  • Pfizer Poised to Raise COVID Vaccine Prices Significantly

    Pfizer Poised to Raise COVID Vaccine Prices Significantly

    Pfizer is preparing to raise prices for its COVID-19 vaccine, potentially buoying the company’s revenue for years.

    Pfizer is one of the leading manufacturers of COVID vaccines, but demand for booster shots has been lower than expected. According to Reuters, the company is looking to make up for that slack demand by raising prices as much as 4x over current prices.

    The company plans to charge anywhere between $110 to $130 a dose once the US transitions from subsidized dosages to a commercialized market. At the same time, Pfizer plans to honor existing agreements it has through 2023.

    Wells Fargo analyst Mohit Bansal said the price hikes could add billions to Pfizer’s annual revenue.

    “This is much higher than our assumption of $50 per shot, and even assuming $80 per shot net price in high-income countries, we see $2 per share upside to our estimates” as a result of the price increase, Bansal wrote in a research note.

  • Intel Giving Employees $250 to Get COVID Vaccine

    Intel Giving Employees $250 to Get COVID Vaccine

    Intel is ramping up its efforts to encourage its employees to get the COVID vaccine, offering a $250 incentive.

    Companies are increasingly rolling out vaccine mandates for their employees as the Delta variant continues to surge around the world. While Intel has not yet gone that route, it is trying to encourage as many as possible to get vaccinated, sweetening the deal with $250.

    Brahm Resnik, a reporter in Phoenix, Arizona, tweeted a copy of the email CEO Pat Gelsinger sent to employees.

    “I am urging you to get a COVID-19 vaccination when it is available in your area,” Gelsinger wrote. “Provided it is possible for you, this is an act that will keep you, your family, your colleagues, and your community safer. I’m a data guy and the data shows that vaccination is a critical element in ending this pandemic. The risk of infection among vaccinated individuals is reduced about three-fold, and the risk of severe disease or death is reduced by ten-fold or greater.” 

    The company is offering a $250 “thank you” to any employee who gets vaccinated, or has already done so. In addition, Intel will provide hourly employees a geo-adjusted $100 food voucher.

    In a recent address, President Biden urged companies to offer incentives of $100 to motivate employees to get vaccinated. Intel is obviously going above and beyond in its efforts.

  • Apple Maps Now Showing COVID-19 Vaccination Locations

    Apple Maps Now Showing COVID-19 Vaccination Locations

    Apple Maps has been updated to display COVID-19 vaccination locations, making it that much easier to set up an appointment.

    As the US rolls out COVID-19 vaccines, one of the biggest challenges is finding a location and setting up an appointment. Some have relied on their local pharmacy, or used websites such as those provided by local governments.

    Apple is making it a bit easier, integrating vaccination locations in Apple Maps.

    Apple today updated Apple Maps with COVID-19 vaccination locations from VaccineFinder, a free, online service developed by Boston Children’s Hospital that provides the latest vaccine availability for those eligible at providers and pharmacies throughout the US. Users can find nearby COVID-19 vaccination locations from the Search bar in Apple Maps by selecting COVID-19 Vaccines in the Find Nearby menu or by asking Siri, “Where can I get a COVID vaccination?”

    The placecard will include operating hours, phone number, address and a link to the provider’s website. Although the data is being provided via VaccineFinder, providers and businesses can also submit their information directly to Apple.

    Along with the data provided by VaccineFinder, healthcare providers, labs, or other businesses can submit information on COVID-19 testing or vaccination locations on the Apple Business Register page. Once validated, Apple may display information about the testing or vaccination locations to people using Apple services such as Apple Maps.

    Apple’s move is good news for Mac and iOS users, removing one more hurdle to people accessing the vaccine.

  • FDA Approves Quidel QuickVue At-Home COVID-19 Test

    FDA Approves Quidel QuickVue At-Home COVID-19 Test

    The U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the Quidel QuickVue At-Home COVID-19 Test, another antigen test where certain individuals can rapidly collect and test their sample at home, without needing to send a sample to a laboratory for analysis.

    The QuickVue At-Home COVID-19 Test is authorized for prescription home use with self-collected anterior nasal (nares) swabs from individuals ages 14 and older or individuals ages 8 and older with swabs collected by an adult. The test is authorized for individuals suspected of COVID-19 by their healthcare provider within the first six days of symptom onset. 

    “The FDA continues to prioritize the availability of more at-home testing options in response to the pandemic,” said Jeff Shuren, M.D., J.D., director of the FDA’s Center for Devices and Radiological Health. “The QuickVue At-Home COVID-19 Test is another example of the FDA working with test developers to bring important diagnostics to the public.”

    In addition to this new prescription home test, Quidel also was issued an EUA in December 2020 for their QuickVue SARS Antigen Test which is authorized for use in laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) to perform high, moderate or waived complexity tests, as well as for point-of-care testing by facilities operating under a CLIA Certificate of Waiver. 

  • FDA: COVID Vaccine Variants Won’t Need Lengthy Testing

    FDA: COVID Vaccine Variants Won’t Need Lengthy Testing

    The Food and Drug Administration (FDA) has indicated that updates to COVID vaccines aimed at virus variants will not need lengthy testing.

    As governments around the world roll out COVID vaccines, a pressing concern is the emergence of variants, such as the UK strain and the South African strain. Experts are concerned that some strains may be more contagious and possibly resistant to existing vaccines.

    To successfully combat existing and emerging strains, it will be important for vaccine manufacturers to be able to quickly bring updated versions of their vaccines, or boosters, to market. The FDA has removed a big hurdle, indicating that vaccine boosters will not require the same lengthy testing as the original vaccine. Instead, manufacturers will be able to adopt a similar approach as that used with flu vaccines.

    “The FDA is committed to identifying efficient ways to modify medical products that either are in the pipeline or have been authorized for emergency use to address emerging variants,” said Acting FDA Commissioner Janet Woodcock, M.D. “We know the country is eager to return to a new normal and the emergence of the virus variants raises new concerns about the performance of these products. By issuing these guidances, we want the American public to know that we are using every tool in our toolbox to fight this pandemic, including pivoting as the virus adapts. We need to arm health care providers with the best available diagnostics, therapeutics and vaccines to fight this virus. We remain committed to getting these life-saving products to the frontlines.”

    The FDA’s new guidance is good news for vaccine manufacturers and citizens alike.

  • Amazon Offers Support For President Biden’s Vaccination Plans

    Amazon Offers Support For President Biden’s Vaccination Plans

    Amazon has congratulated President Biden and Vice President Harris on their inauguration and offered its support in ramping up the vaccine rollout.

    One of President Biden’s biggest challenges will be significantly increase the pace of the country’s vaccination efforts. In an open letter, Amazon’s Dave Clark, CEO, Worldwide Consumer, made it clear the company is ready to assist.

    We have an agreement in place with a licensed third-party occupational health care provider to administer vaccines on-site at our Amazon facilities. We are prepared to move quickly once vaccines are available. Additionally, we are prepared to leverage our operations, information technology, and communications capabilities and expertise to assist your administration’s vaccination efforts. Our scale allows us to make a meaningful impact immediately in the fight against COVID-19, and we stand ready to assist you in this effort.

    Clark also makes the case that Amazon’s workers, many of whom are considered essential workers, should be among the first vaccinated.

    There is no word yet on whether the new administration will take Clack up on the offer, but it’s a safe bet no options are off the table.

  • Hackers Targeting COVID-19 Vaccine Companies

    Hackers Targeting COVID-19 Vaccine Companies

    Microsoft has revealed that “nation-state” actors have been targeting the companies and researchers working on COVID-19 vaccines.

    According to Microsoft, one of the groups, Strontium, originates in Russia. Two others hail from North Korea. The three groups have targeted companies and researchers in Canada, France, India, South Korea and the US.

    “Among the targets, the majority are vaccine makers that have Covid-19 vaccines in various stages of clinical trials,” writes Tom Burt – Corporate Vice President, Customer Security & Trust. “One is a clinical research organization involved in trials, and one has developed a Covid-19 test. Multiple organizations targeted have contracts with or investments from government agencies from various democratic countries for Covid-19 related work.”

    To help protect companies and researchers, Microsoft has made its AccountGuard available at no cost to COVID-19 healthcare providers.

    “Organizations are also taking steps to protect themselves. In April, we announced that we were making AccountGuard, our threat notification service, available to health care and human rights organizations working on Covid-19,” continues Burt. “Since then 195 of these organizations have enrolled in the service and we now protect 1.7 million email accounts for health care-related groups. Any health care-related organizations that wish to enroll can do so here.”

    It’s a sad state of affairs that hackers would continue to take advantage of the COVID-19 pandemic. Microsoft is to be commended for its efforts to help protect researchers.

  • Coronavirus: Rescale Partners With Microsoft Azure and Google Cloud For Vaccine Research

    Coronavirus: Rescale Partners With Microsoft Azure and Google Cloud For Vaccine Research

    In the race to create a COVID-19 vaccine, Rescale has partnered with both Microsoft Azure and Google Cloud.

    Rescale is a leader in enterprise big compute and is offering its high performance computing resources to research teams working on vaccines or test kits—at no cost. Thanks to the partnerships, “researchers can rapidly run simulations in the cloud without setup time or IT teams using Rescale’s turnkey platform combined with cloud computing resources from Google Cloud Platform and Microsoft Azure.”

    Another significant advantage of the cloud partnership is the ability for research teams around the globe to seamlessly collaborate and combine their efforts.

    “Rescale’s platform can provide access to high-performance computing resources that can help accelerate key processes and enable stronger collaboration,” said Manvinder Singh, Director, Partnerships at Google Cloud. “As a partner of Rescale, we’re grateful that they will make these resources, including Google Cloud computing capabilities, available to more researchers and organizations.”

    Greg Moore, Corporate Vice President, Microsoft Health added, “We’re inspired to team up with Rescale in the fight against time to help provide answers to address COVID-19. To enable researchers and organizations to develop new therapeutics and vaccines faster, we’re working together to accelerate the availability of Azure supercomputers in the cloud.”

    Rescale is to be commended for offering their HPC resources at no cost to researchers who are desperately trying to develop vaccines and more efficient ways of testing. The announcement is also a prime example of how the coronavirus pandemic is hastening a large-scale migration to cloud computing.

  • Flu Shots: The Pros And Cons Of The Vaccine

    It’s flu season, the time of year when sneezes, coughs and fevers seem almost inevitable.

    One of the ways you can try to avoid catching the flu is by getting an annual flu shot. Some doctors insist that flu shots are a great way to avoid the most common flu strains, and many people swear by them.

    Others believe that flu shots are unnecessary and can actually cause you to get the flu more easily.

    If you are having a hard time deciding whether or not you should get a flu shot, consider the pros and cons before you make your decision.

    Effectiveness

    Pro: Flu shots can be very effective at protecting against several strains of flu viruses.

    Con: Flu shots can’t protect you against every strain of flu virus and you could still end up getting the flu in spite of getting the shot.

    Side Effects

    Con: Some people experience side effects after getting a flu shot. These can range from a mild fever and flu-like symptoms to contracting the flu from the vaccine.

    Pro: Most people who get a flu shot do not suffer from any side effects.

    Accessibility

    Pro: Flu shots are easy to get and if you don’t want to make an appointment with your doctor for one, you will likely be able to get one at a local pharmacy. The vaccine is administered quickly and you can even get one on your lunch break.

    Cons: Some types of insurance will not cover flu shots or flu shots from certain clinics or pharmacies. Check with your health insurance company to see what types of vaccines are covered under your policy.

    Do you think flu shots are worth getting?

  • Jenny McCarthy Says She’s Pro-Vaccination

    Model and The View host Jenny McCarthy has claimed that she was misunderstood on her stance on vaccines, firing back with a column on the Chicago Sun-Times.

    Just last month, the “Playboy Playmate of the Year” was called out by fans saying she’s anti-vaccination. In recent years, McCarthy has voiced out that vaccines administered during childhood are tied to autism among children.

    In her column, McCarthy claimed that her opinion on the matter has not changed or altered, but that she is in the gray zone about the topic.

    Through the years, McCarthy has been linked to anti-vaccination ideologies, claiming that vaccines have toxins. However, doctors have said that vaccines contain little amounts of toxins for it to take effect the way McCarthy imagined it to be.

    Oddly, the host is also a supporter of botox, a procedure that contains botulinum, one of the most lethal toxins that exists. In an interview several years ago, she admitted she loves botox, calling it a savior.

    However, in her column for the Sun-Times, she clarified that she is pro-vaccine, she is just looking at alternative schedules for injections, without completely eliminating the vaccine.

    She continued to say that her son Evan, who has autism, encouraged her to look at options, questioning the ‘one size fits all’ practice of vaccination schedules.

    She questions whether a healthy, able-bodied child should receive the same number of shots and have a similar vaccination plan with a child who has a weaker immune system.

    McCarthy insists on her son getting one vaccination shot per visit instead of the current practice of multiple shots. She believes that parents should have the right to ask questions regarding their children’s vaccination.

    She added that she is not discouraging conversations about children’s healthcare. She closed her article by saying that one size does not fit all, and that gray should still be an option.

    Vaccines Don’t Cause Autism


    Image via YouTube

  • Mumps Outbreak at OSU Renews Prevention Discussion

    Mumps continues to make a comeback this year, recently hitting Ohio State University after making the rounds at Fordham University last month. The number of infections in reports steadily increased: 11, then 13, 23, and finally 28. Victims included students and a member of the OSU staff.

    Since students have returned to campus after spring break, the issue has become preventing the virus from spreading throughout the student body. Many are wondering how to protect themselves from the virus.

    The measles, mumps, and rubella or MMR vaccination is the standard prevention tool in stopping such outbreaks from occurring. The vaccine is 80% effective in protecting a person from catching mumps. The virus’ resurgence has raised many questions about dropping vaccination rates, caused in recent years by faulty research indicating a connection between autism and vaccinations and further bolstered by anti-vaccine advocates such as Jenny McCarthy.

    Thankfully, 90 percent of U.S. children still receive their recommended vaccinations, enough to maintain herd immunity against mumps. 15 U.S. states do fall below the 90 percent, but neither Ohio nor New York made that list.

    Why the mumps outbreaks, then? Experts are not sure, but the cloistered college environment may be a cause. 80 percent effectiveness is plenty short of foolproof, especially on a crowded campus of over 50,000 students that does not require standard vaccines for admission.

    As such, experts are reiterating the time-tested prevention tips of frequent hand-washing and absolutely no drink sharing. The mumps are infectious for a full 25 days, and five of those are before most people even know they are infected. Watch for common symptoms such as fever, headache, and loss of appetite, as well as the more serious telltale sign of mumps: salivary gland swelling.

    The OSU Student Health Services tweeted an endorsement of the MMR vaccine, along with some extra advice to those sickly but dedicated students thinking of attending classes while ill.

    https://twitter.com/buckmd/status/445907477662429184

    Image via Wikimedia Commons

  • HIV Prevention Shot Shows Promise

    HIV Prevention Shot Shows Promise

    An experimental drug to prevent HIV has been showing a lot of promise, according to researchers. At the AIDS conference on Tuesday, AIDS expert Dr. Robert Grant from the Gladstone Institute said that the drug has been tested on two groups of monkeys and studies show that it has protected them from getting the infection.

    If the drug proves to be safe, it will allow prevention of HIV when injected every three months. This may be a solution to the pills that must be taken daily to lower the risk of getting HIV. One of the available drugs today is Truvada – a pill that is shown to reduce the risk of getting HIV by as much as 90%.

    The new study is done on a long-acting drug that is being tested on macaques that were exposed to the human-monkey version of HIV twice for 11 weeks. Of the dozen monkeys, six were given the experimental drug, while the other six were given dummy shots. The results showed the six monkeys who were given the drug remained protected from the virus, while the other six were infected with HIV.

    In another study, eight monkeys were given the experimental drug four weeks apart, and another eight monkeys were given dummy shots. All the monkeys were then exposed to the virus once a week for the duration of eight weeks. Just like the previous study, monkeys who were given the drug were protected and those who got dummy shots were infected.

    A study was also conducted to see how long a single shot of the experimental drug would last. Results indicated that on average, a shot of the drug protected a dozen monkeys for 10 weeks. The dosage used was paralleled to the dosage that would be given to humans every three months.

    The results of the studies showed real promise and according to infectious disease specialist from the University of California, Dr. Judith Currier, the research will be moving forward into testing the drug on humans.

    More about HIV and Flu vaccines

    Image via YouTube

  • New Flu Vaccine: No More Needles?

    New Flu Vaccine: No More Needles?

    It’s not an easy thing to own up to, but a lot of people are afraid of needles. The dreaded “shot” has kept many an adult out of the doctor’s office. Even as we tell sobbing little kids that it’s important to get flu vaccinations to prevent illness, how many have passed on the opportunity themselves?

    Now it’s finally looking like the nightmare may be over for those with a needle phobia.

    A patch is being developed by researchers at the Georgia Institute of Technology that may make it possible to take care of flu vaccinations entirely on your own. The researchers found subjects were successfully able to apply the flu patch to themselves with little instruction.

    Surprise, surprise: The subjects also stated that they preferred the patch to a needle in the arm.

    Mark Prausnitz, a professor of biomolecular engineering at the Georgia Institute of Technology, says that his team dreams of flu vaccine patches that are readily available in stores or by mail for persons to have and apply themselves.

    “We want to get more people vaccinated, and we want to relieve health care professionals from the burden of giving these millions of vaccinations.”

    This burden is a greater reality than many Americans realize. It’s not uncommon for vaccines to “run out”, making them unavailable for the most vulnerable members of the population who need them—children and the elderly.

    The patch features 50 tiny needles (don’t faint, they’re actually very small…) that barely break the surface of the skin.

    The study is meant to demonstrate that this method of administration has greater possibilities than the traditional shot administered in doctor’s offices and at pharmacies.

    There is additional evidence that suggests this method may also be more effective at protecting from the flu than a shot.

    Those of us that utterly despise needles and are seeking any and every alternative no doubt are hoping for more research and funding that will allow this considerably less scary alternative to become the new vaccination standard.

    Image via Wikimedia Commons

  • Mumps Outbreak: 14 Fordham Dorm Students Infected Since January

    An outbreak of the mumps has spread across two of the Fordham University campuses, with the number of infected students rising each day since Monday.

    “The University community was notified that there has now been one case of suspected mumps reported at the Lincoln Center campus, and four new cases at Rose Hill,” officials from Fordham reported included in a Thursday statement, adding that it brought the week’s total “number of cases to 13 University wide.”

    Combined with the January infection, Fordham’s total cases of mumps now add up to 14 so far this year.

    According to the New York Daily News, twelve of the cases arose at Fordham’s Bronx campus, while the other occurred at the Manhattan Lincoln Center campus. A university employee claimed that the students attending the Bronx campus who fell ill all shared in common that they lived in dormitories.

    Fordham officials stated, “All the students with suspected mumps infections have either returned home or have been isolated from other residents during the infectious phase of the illness,” adding that, “Typically mumps patients are contagious for two days prior to the outbreak of symptoms and five days after.”

    Freshman student Johnathan Agostino indicated, “The thing is, just to get into Fordham you need to be vaccinated for mumps. So nobody knows if those kids got a bad vaccine or what,” and insisted, “I just know I’m going straight to the health center if I see any symptoms.”

    According to the Center for Disease Control and Prevention, some symptoms Johnathan might want to look for include: fever, headaches, achey muscles, gland swelling, appetite decrease, and lethargy. However, these can show up 16 to 18 days following actual infection.

    Although students must indeed receive the MMR (mumps, measles and rubella) vaccine, such doesn’t always guarantee one won’t become infected. Dr. Marguerite Mayers, a pediatric infectious disease expert with Montefiore Children’s Hospital, says that while as much as 90 percent of vaccinated people become immune to the virus, “there’s still a small group of individuals who don’t get any protection to vaccines, and that group represents a population that’s susceptible. So when mumps viruses are brought into the community, it will spread.”

    She also described how the vaccine’s lack of effectivity in said cases might be less about personal physiology for some people and more about how long ago they were vaccinated. For some of those vaccinated as children, she explains, “the antivirus may have waned” between then and adulthood.

    Dr. Mayers added that mumps are almost never fatal – a fact confirmed in Fordham University’s statement:

    “Mumps in college-age men and women usually runs its course without any lasting effects,” they explained, going on to add, “Nonetheless, the University is trying to see what connection there might be among the affected students while stepping up the frequency and intensity of cleanings in communal bathrooms.”

    Image via Youtube

  • Flu Running Rampant; Blamed For Multiple Deaths

    The flu virus is causing widespread panic again this year, with the largest outbreak since the H1N1 “swine flu” pandemic that swept through the U.S. in 2009.

    Several deaths have already been reported nationwide this season, with 4 dead in Michigan and 5 fatalities already reported in California since October 1.

    The H1N1 strain has been one of the most deadly types of the influenza virus ever seen, and is now causing dozens of Americans to be placed on life support in the Michigan area.

    Adults and children are both being sent to the University of Michigan hospital in many cases for their need of the specialized life support being offered. Life support at University of Michigan Health System’s hospitals includes not only a ventilator, but also an oxygenation technology in which breathing can be done for patients who can no longer do so on their own.

    According to officials in Michigan, it appears that the most ill patients either did not receive a flu shot, or got one too late, already having been exposed to the illness. The flu vaccine apparently takes at least two weeks to be fully effective in fighting off the flu.

    Traditionally, the flu has been known to be most hazardous to small children and older adults, but the H1N1 virus is more common in teenagers and young adults.

    Doctors nationwide urge people to still get vaccinated, as the peak of flu season usually occurs in January and February.

    Main image courtesy Alcibiades via Wikimedia Commons.

  • New Bird Flu Infects First Human

    New Bird Flu Infects First Human

    Zoonosis occurs when a disease or sickness in a non-human animal is transmitted to a human being. Approximately 61% of 1415 pathogenic infections to human beings are zoonotic. The first case of a bird-to-human transmission of infection came in China in 1996. Since its inception, the H5N1 flu strain has killed more than 600 people, most of those residing in Asia. Over those 17 years, however, there have only been a few cases of avian flu infecting human beings, perhaps the most infamous being the H1N1 pandemic which broke out in 2009-10. However, there are now reports of a new strain infecting a human being.

    In May of this year, a 20 year old Taiwanese woman was hospitalized after displaying flu-like symptoms – short of breath, a high fever, and severe coughing. Upon noting the symptoms, the doctors prescribed the woman Tamiflu and other antibiotics, and then sent her on her way. After the Taiwanese Centre for Disease Control studied the results of her throat-swab, doctors had cause to sound the alarm. The woman’s sickness was identified as the H6N1 strain of avian flu, a disease which had been present in chickens on the island since the 1970’s but had yet to become zoonotic.

    Due to the potential severity of the illness, Taiwanese officials began investigating the origins of the flu and whether or not it was present in people who had been in contact with the 20 year old patient. Officials could find no immediate cause as to why or how the woman obtained the virus considering she worked as a clerk in a butcher shop and had no contact with live birds. In questioning 36 of her closest contacts, doctors only discovered flu-like symptoms in 6 people, none of which were infected with the H6N1 strain.

    When investigating this particular strain even closer, doctors discovered unsettling news – the virus had undergone a mutation in its haemagglutinin, a binding protein, allowing it to bind to human cells. ‘‘The question again is what would it take for these viruses to evolve into a pandemic strain?’’ questioned virologist Marion Koopmans, who works for the National Institute for Public Health and the Environment in the Netherlands.

    Luckily, recent reports have been released which show progress being made toward developing effective antibodies and medicines to combat the bird flu. Swiss drug-maker Novartis and Rockville, Maryland biotech company Novavax have both conducted independent clinical trials in which they have seen successful results from vaccines engineered to actively combat the bird flu. The aim of the vaccine is to boost antibodies whose particular job would be to attack the H7 and N9 proteins which stick out from the rest of the bird virus. In the Novavax study, the vaccine produced antibodies fighting against the “H” protein at an 81% success rate and produced antibodies against the “N” protein at a 90% success rate.

    While none of the avian flu strains have yet to be transmitted from human-to-human, the threat always exists. The development of these new antibodies hopefully ensures that the end of the world will not be due to avian flu, but rather the zombie apocalypse, something we all know we truly want.

    Image via Wikimedia Commons

  • Whooping Cough Cases on the Rise

    Whooping Cough Cases on the Rise

    Cases of whooping cough, also known as pertussis, are rising in some areas of the United States. Nevada is one area that has seen a rise in whooping cough cases in 2013, with Clark County having 103 reported cases of the illness so far this year. The Centers for Disease Control and Prevention (CDC) says that the best way to avoid whooping cough is by getting a vaccine.

    For those who aren’t too familiar with whooping cough, the CDC describes it as “a highly contagious respiratory tract infection. Although it initially resembles an ordinary cold, whooping cough may eventually turn more serious, particularly in infants.” While many people receive a whooping cough vaccine as a child (doses of the DTaP vaccine start at 2 months), the CDC also recommends that all adults have their vaccine updated, since it can wear off over time.

    While cases of pertussis in the U.S. have generally declined over the years, some parts of the country are seeing higher rates of whooping cough over previous years. According to Las Vegas Review Journal, around 16,000 whooping cough cases have been reported to the CDC as of September 15, with 13 states, including Nevada, reporting an increase compared to 2012. No deaths resulting from whooping cough have been reported in Nevada.

    Nancy A. Wood, an infection-prevention specialist at Canton-Potsdam Hospital in New York, says that the reason whooping cough cases are rising is because some people aren’t getting vaccinated. “Older people who haven’t gotten whooping cough vaccination are getting whooping cough and then giving it to the children,” Wood said. Wood also says that some people choose not to vaccinate their kids, which leaves them “vulnerable.” Wood didn’t specifically mention if the areas in Nevada with higher whooping cough cases have a lower rate of people with the vaccination.

    Most new parents do get their children vaccinated for whooping cough, but the numbers of parents who hare having their children opt out of the vaccination are increasing. One reason listed for opting out is the potential side effects. According to the CDC, while rare, possible side effects include “seizure, high fever, serious allergic reaction, long-term seizures, coma, or lowered consciousness and permanent brain damage.” Choosing not to vaccinate is fairly controversial, as seen below. Do you think everyone should be vaccinated? Respond below.

    Symptoms of Whooping Cough

    While whooping cough is relatively rare, it’s helpful to know the signs of symptoms of the illness, which the Mayo Clinic provides.

    Once you become infected with whooping cough, it can take one to three weeks for signs and symptoms to appear. They’re usually mild at first and resemble those of a common cold:

    Runny nose
    Nasal congestion
    Sneezing
    Red, watery eyes
    A mild fever
    Dry cough

    After a week or two, signs and symptoms worsen. Thick mucus accumulates inside your airways, causing uncontrollable coughing. Severe and prolonged coughing attacks may:

    Provoke vomiting
    Result in a red or blue face
    Cause extreme fatigue
    End with a high-pitched “whoop” sound during the next breath of air

    Image via YouTube